Tianlong, established in 1997, has been a trailblazer in the research and development and production of nucleic acid testing instruments and reagents. As a leader in the field, Tianlong offers a wide array of PCR solutions, including nucleic acid extractors utilizing the magnetic beads method, PCR thermal cyclers, real-time PCR systems, and automatic nucleic acid workstations. These advanced PCR solutions have earned Tianlong over 70 China NMPA approvals and more than 120 international certifications, making their products a trusted choice in more than 100 countries and regions worldwide.
Advanced Technology in PCR Solutions
Tianlong’s PCR solutions are built on cutting-edge technology that ensures precision and reliability in diagnostic processes. The nucleic acid extractors, using the magnetic beads method, deliver high efficiency in sample preparation, which is crucial for accurate test results. PCR thermal cyclers and real-time PCR systems offered by Tianlong provide rapid and reliable nucleic acid amplification and detection, essential for various diagnostic applications. These solutions are designed to meet the rigorous demands of modern healthcare, providing consistent and accurate results.
Global Recognition and Market Reach
The global recognition of Tianlong’s PCR solutions is reflected in the numerous certifications and approvals the products have received. With more than 70 China NMPA approvals and over 120 international certifications from regions such as the European Union, the United States, and South Korea, Tianlong’s products adhere to the highest international standards. The widespread adoption of Tianlong’s PCR solutions in over 100 countries and regions underscores the company’s commitment to quality and innovation, making it a trusted partner in the global healthcare landscape.
Contributions to Public Health and Research
Tianlong’s PCR solutions have played a significant role in clinical diagnostics, epidemic prevention and control, food safety, and scientific research. During the COVID-19 pandemic and other major epidemics, such as avian influenza and Ebola, Tianlong’s products and team have made substantial contributions to disease prevention and control. The reliability and effectiveness of Tianlong’s PCR solutions have been instrumental in managing public health crises, highlighting the company’s pivotal role in global health initiatives.
Conclusion
Tianlong’s comprehensive PCR solutions exemplify the company’s dedication to advancing diagnostic technology and improving global healthcare. With a strong focus on innovation, quality, and reliability, Tianlong continues to lead the way in providing essential tools for clinical diagnostics, public health, and scientific research. As the demand for precise and efficient diagnostic solutions grows, Tianlong remains at the forefront, delivering products that make a significant impact on health outcomes worldwide.